Singapore stocks ended 0.7 per cent lower on Tuesday (Jun 20), led by a decline in Sembcorp Industries and Keppel Corporation the day after the Energy Market Authority (EMA) said it will introduce a temporary price cap on wholesale electricity prices. At the close, Sembcorp Industries lost 9.2 per cent or S$0.52 to S$5.15, with 24.4 million shares worth S$127.5 million having changed hands. Keppel Corp ended 5.2 per cent or S$0.36 lower at S$6.60, after eight million shares worth S$53.5 million changed hands.

Wall Street stocks retreated on Tuesday (Jun 20), giving back a fraction of the gains from recent weeks. Major indices spent most of the day in the red, finishing modestly lower. The Dow Jones Industrial Average shed 0.7 per cent to 34,054.07. The broad-based S&P 500 dipped 0.5 per cent to 4,388.73, while the tech-rich Nasdaq Composite Index lost 0.2 per cent at 13,667.29.

Top gainers & losers


***We are ceasing coverage of Del Monte Pacific Ltd and First Sponsor Group Ltd with immediate effect due to a reallocation of resources. The previous recommendation can no longer be relied upon.***


Keppel Corporation has been awarded a contract by the Urban Redevelopment Authority (URA) to design, build, own and operate a new large-scale district cooling system (DCS) plant for 30 years located in the Jurong Lake District (JLD). The contract is expected to generate about $950 million for Keppel, comprising payments from real estate developers, owners and occupants for the design and building of the DCS, as well as the supply of chilled water and operations and maintenance of the DCS over 30 years. The DCS will have a design capacity of 29,000 Refrigeration Tonnes (RT) to supply chilled water and related services to an estimated 1.4 million square metre gross floor area (sqm GFA).

Digital Life Line, a privately held associate company of catalist-listed Disa (Digital Safety) has signed a tri-party licensing agreement with the National University Hospital (NUH) and National University of Singapore (NUS) on June 19 to commercialise the Automated Visual Acuity Test device (AVAT), which measures eyes’ ability to distinguish shapes at a distance and Smart, User-friendly Portable Reliable Automated perimetry device (SUPRA), which tests visual fields. The technology was developed at a unit of NUS’ Medicine faculty, and refined after testing in the clinical setting at NUH. These are portable devices that are able to “decentralise” the current care model of conducting eye screening and monitoring of eye diseases.

Valuemax Group launched on Tuesday (Jun 20) an issue of unsecured commercial paper in digital securities at an interest rate of 5.15 per cent with a maturity of three months. The mainboard-listed group, offering pawnbroking and secured moneylending services, and engaging in the retail and trading of jewellery and gold, said in a bourse filing on Tuesday that it expects to raise S$10 million to S$20 million from accredited and institutional investors from the issuance, to be listed on the SDAX digital platform. The issuance is part of a S$100 million multi-series unsecured commercial paper facility programme launched by ValueMax on the digital platform on Tuesday.

Q&M Dental Group has agreed to transfer its 80% beneficial stake in Shanghai Chuangyi Investment & Management Co., Ltd. to Shanghai Zhibao Investment Consulting Co., Ltd for a consideration of RMB500,000 ($93,533.38). Shanghai Q&M Management & Consulting Co., Ltd., through which Q&M owns its stake in Shanghai Chuangyi, entered into a transfer agreement with Wong Kee Hau, Wu Jun and Shanghai Zhibao Investment Consulting on June 19. Q&M has also entered into a settlement and termination deed with Wong and Wu on June 19 where all parties have agreed to a full and final settlement of any disputes, claims and counter claims between the parties. The disputes were in relation to the breach of a non-competition agreement (NCA) that was entered into by Aoxin Q & M Dental Group Limited (Aoxin), Wong, Wu and Wu Jian on Nov 26, 2012. The benefit of the NCA was subsequently assigned to Q&M on Feb 18, 2021 through a deed of assignment between Aoxin and itself.


Chinese tech giant Alibaba said on Tuesday (Jun 20) that it will replace its top boss, in a surprise move at the e-commerce titan as it looks to recover from years of slow growth caused by weak consumer spending and a regulatory crackdown. Under the reshuffle, Joseph Tsai will serve as chairman and Eddie Wu as CEO – replacing Daniel Zhang, who holds both roles. Both appointments will take effect on Sep 10. After the transition, Zhang will continue to serve as chairman and CEO of Alibaba Cloud Intelligence Group, the company said.

Nasdaq-listed Grab Holdings, under pressure to turn around, is cutting 1,000 jobs, equivalent to 11% of its headcount, citing a memo sent by CEO Anthony Tan. The cuts, the biggest since the start of the pandemic, were not “a shortcut to profitability” but a strategic reorganisation to adapt to the business environment, says Tan. Tan maintains that even without the retrenchments, the company is on track to hit its target for adjusted EBITDA breakeven this year. For its 1QFY2023, Grab’s revenue increased by 130.3% y-o-y to US$525 million but remains in the red to the tune of US$250 million.

Eli Lilly will buy Dice Therapeutics for about US$2.4 billion in cash, the company said on Tuesday (Jun 20), bolstering its immune disease-related portfolio with an experimental pill to treat psoriasis. The company has been looking to bulk up its immunology pipeline, even as it bets on potential blockbuster obesity drug tirzepatide, also known as Mounjaro, to drive future growth. The deal helps Lilly gain Dice’s lead drug, DC-806, an oral pill being tested in a mid-stage trial to treat skin condition psoriasis.

UBS Group faces hundreds of millions of dollars in penalties following investigations by several regulators into Credit Suisse’s dealings with Archegos Capital. The bank had asked Switzerland’s financial regulator Finma, the US Federal Reserve and the UK’s Prudential Regulation Authority to publish their findings and announce any penalties jointly at the end of next month, citing four people briefed on the plans. The Fed’s fine over Archegos may be as high as US$300 million, while the PRA could slap a penalty of up to US$128 million, while the final number could be lower. Finma doesn’t have the authority to impose fines.

European antitrust regulators are preparing to launch a formal investigation into software giant Adobe’s $20 billion buyout deal for cloud-based designer platform Figma later this year. Adobe is in the preliminary phase of the regulatory process and having constructive discussions with British, EU, and U.S. regulators about the deal while Figma looks forward to continued conversations with regulators, the companies said in separate emailed statements.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Guest Presentation by Uni-Asia Group Limited [NEW]

Date: 23 June 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/22nv3kyj

Guest Presentation by IREIT Global [NEW]

Date: 28 June 2023

Time: 1pm – 2pm

Register: https://tinyurl.com/3n6nhafn

Guest Presentation by United Hampshire US REIT [NEW]

Date: 28 June 2023

Time: 7pm – 8pm

Register: https://bit.ly/3pIRkUl

Strategy & Stock Picks 3Q23 (US)

Date: 13 July 2023

Time: 7.30pm – 9pm

Register: https://tinyurl.com/5n7cuwtm

Strategy & Stock Picks 3Q23 (SG)

Date: 15 July 2023

Time: 10am – 12pm

Register: https://tinyurl.com/2fsww93d

POEMS Podcast:

Research Videos

Weekly Market Outlook: City Developments, Phillip On The Ground, Tech Analysis, SG Weekly & More!
Date: 19 June 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com